JP2016531927A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531927A5
JP2016531927A5 JP2016543278A JP2016543278A JP2016531927A5 JP 2016531927 A5 JP2016531927 A5 JP 2016531927A5 JP 2016543278 A JP2016543278 A JP 2016543278A JP 2016543278 A JP2016543278 A JP 2016543278A JP 2016531927 A5 JP2016531927 A5 JP 2016531927A5
Authority
JP
Japan
Prior art keywords
composition
cancer
ssrna
papmv
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016543278A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016531927A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2014/050908 external-priority patent/WO2015039255A1/en
Publication of JP2016531927A publication Critical patent/JP2016531927A/ja
Publication of JP2016531927A5 publication Critical patent/JP2016531927A5/ja
Pending legal-status Critical Current

Links

JP2016543278A 2013-09-19 2014-09-19 癌治療でのパパイヤモザイクウイルス及びウイルス様粒子 Pending JP2016531927A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361880156P 2013-09-19 2013-09-19
US61/880,156 2013-09-19
US201361886481P 2013-10-03 2013-10-03
US61/886,481 2013-10-03
PCT/CA2014/050908 WO2015039255A1 (en) 2013-09-19 2014-09-19 Papaya mosaic virus and virus-like particles in cancer therapy

Publications (2)

Publication Number Publication Date
JP2016531927A JP2016531927A (ja) 2016-10-13
JP2016531927A5 true JP2016531927A5 (OSRAM) 2017-10-26

Family

ID=52688058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016543278A Pending JP2016531927A (ja) 2013-09-19 2014-09-19 癌治療でのパパイヤモザイクウイルス及びウイルス様粒子

Country Status (7)

Country Link
US (1) US20160228541A1 (OSRAM)
EP (1) EP3046565A4 (OSRAM)
JP (1) JP2016531927A (OSRAM)
CN (1) CN105899217A (OSRAM)
CA (1) CA2924819A1 (OSRAM)
MX (1) MX2016003653A (OSRAM)
WO (1) WO2015039255A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086095B2 (en) 2012-10-09 2018-10-02 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
US11193111B2 (en) 2013-01-17 2021-12-07 Case Western Reserve University Viral nanoparticle multimers
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
JP6731405B2 (ja) * 2014-11-07 2020-07-29 ケース ウエスタン リザーブ ユニバーシティ ウイルス粒子を用いた癌免疫療法
US10624975B2 (en) 2015-06-29 2020-04-21 Case Western Reserve University Anticancer drug-containing plant virus particles
US10478510B2 (en) 2015-07-16 2019-11-19 Case Western Resrve University Plant virus particles for delivery of antimitotic agents
US11433123B2 (en) 2016-07-21 2022-09-06 Case Western Reserve University Sustained release cowpea mosaic virus or virus-like particle therapeutic constructs for the treatment of cancer
US12433840B2 (en) 2016-11-03 2025-10-07 Case Western Reserve University Melt processed viral nanoparticle constructs
AU2017354004C1 (en) 2016-11-03 2023-08-31 Case Western Reserve University Melt processed viral nanoparticle constructs
US11590183B2 (en) 2017-03-10 2023-02-28 Case Western Reserve University Cancer immunotherapy using virus particles
US11672840B2 (en) 2017-05-17 2023-06-13 Case Western Reserve University Anticancer trail-targeted plant virus particles
WO2019084555A1 (en) 2017-10-27 2019-05-02 Case Western Reserve University TYMOVIRUS VIRUSES AND VIRAL TYPE PARTICLES USEFUL AS NANOVECTORS FOR IMAGING AND THERAPEUTIC AGENTS
US11390853B2 (en) 2019-04-26 2022-07-19 Case Western Reserve University Freeze dried viral nanoparticle constructs
US11896676B2 (en) 2019-08-07 2024-02-13 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
US11529430B2 (en) 2019-12-20 2022-12-20 Case Western Reserve University Polydopamine decorated tobacco mosaic theranostic virus nanoparticles
US12203073B2 (en) 2019-12-20 2025-01-21 Case Western Reserve University Plant viral RNA delivery nanoparticles and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05000287A (es) * 2002-07-05 2005-09-08 Leclerc Denis Particula viral adyuvante.
US8101189B2 (en) * 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
MX2013013228A (es) * 2011-05-13 2013-12-12 Folia Biotech Inc Particulas similares a virus y proceso para prepararlas.

Similar Documents

Publication Publication Date Title
JP2016531927A5 (OSRAM)
Anestopoulos et al. Epigenetic therapy as a novel approach in hepatocellular carcinoma
PH12019501130A1 (en) Viral delivery of neoantigens
MA39907A (fr) Nouvelle immunothérapie contre plusieurs tumeurs, du sang, notamment la leucémie aiguë myéloïde (lam)
NZ732211A (en) Combination immunotherapy approach for treatment of cancer
EA201690016A1 (ru) Новый метод иммунотерапии нескольких видов опухолей, таких как рак легкого, включая нмрл
TW201613956A (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
PH12021551208A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
WO2015109180A3 (en) Compositions and methods for treatment and detection of cancers
JP2016538344A5 (OSRAM)
JP2013166763A5 (OSRAM)
JP2012513418A5 (OSRAM)
MX383966B (es) Composiciones y métodos mejorados para la entrega viral de neoepítopos y usos de estos.
JP2018522880A5 (OSRAM)
MX2019008105A (es) Virus.
SG10201806064XA (en) Anti-tumor compositions and methods
WO2015120482A3 (en) Recurrent fusion genes identified in high-grade serous ovarian carcinoma
JP2016516394A5 (OSRAM)
MX2014001675A (es) Peptidos de mphosph1 y vacunas que incluyen los mismos.
JP2016108250A5 (OSRAM)
JP2015000064A5 (OSRAM)
EP4461371A3 (en) Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
PH12016502008A1 (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid lukemia (aml)
WO2011140634A3 (en) The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof
JP2011520996A5 (OSRAM)